# Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015)

> **NCT02927210** · PHASE1 · COMPLETED · sponsor: **Kimberly Myer** · enrollment: 106 (actual)

## Conditions studied

- Healthy Men
- Male Contraception

## Interventions

- **DRUG:** Dimethandrolone Undecanoate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02927210
- **Lead sponsor:** Kimberly Myer
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-15
- **Primary completion:** 2024-11-07
- **Final completion:** 2025-04-29
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2025-10-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02927210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02927210, "Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02927210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*